Earnings3386COSMO BIO COMPANY,LIMITED
Cosmo BIO Company Reports Q1 Revenue of 3.3 billion, Up 8%
TOKYO, May 08 (Pulse News Wire) – Cosmo Bio Company, Limited (3386.T) reported consolidated results for Q1 FY2026 (ending December 2026). Revenue was ¥3.3 billion (+7.7% YoY).
Operating profit was ¥271 million (-1.0%). net profit attributable to shareholders was ¥222 million (+4.7%).
Total assets stood at ¥12.5 billion with an equity ratio of 75.4%. The company declared an annual dividend of ¥25 per share.
The full-year forecast for the current fiscal year is revenue of ¥11.4 billion (+5.9%).
Financial results — FY2026/12 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥3,331M | +7.7% |
| Operating profit | ¥271M | -1.0% |
| Net profit | ¥222M | +4.7% |
Next period forecast
Revenue
¥11,400M
+5.9%Op. profit
¥270M
-21.3%Net profit
¥220M
-34.7%Source: TDNet filing · Figures in millions of yen
End of article